Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00811200 | Treatment Of Radiation Retinopathy Trial(TORR) | unknown | Phase 2 / Phase 3 | 220 | Leiden University Medical CenterOTHER | 0 | Jul 2, 2009 | clinicaltrials |
| NCT00675727 | Safety Study of CADI-05 in Patients With Advanced Stage Melanoma | terminated | Phase 1 / Phase 2 | 20 | Cadila PharnmaceuticalsINDUSTRY | 1 | Jun 11, 2009 | clinicaltrials |
| NCT00733798 | A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma | terminated | Phase 1 / Phase 2 | 58 | TransMolecularINDUSTRY | 1 | May 11, 2009 | clinicaltrials |
| NCT00308607 | Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma | completed | Phase 2 | 27 | University of TurkuOTHER | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00043368 | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | completed | Phase 2 | 31 | PfizerINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00243594 | Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | completed | Phase 1 / Phase 2 | 40 | Radboud University Medical CenterOTHER | 1 | Feb 19, 2009 | clinicaltrials |
| NCT00847106 | Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients | completed | Phase 1 / Phase 2 | 15 | Radboud University Medical CenterOTHER | 0 | Feb 19, 2009 | clinicaltrials |
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 2 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00304200 | Temodar and Sutent as Therapy for Melanoma | terminated | Phase 1 / Phase 2 | 7 | Northern California Melanoma CenterOTHER | 1 | Feb 5, 2009 | clinicaltrials |
| NCT00189332 | Use of 852A in Metastatic Cutaneous Melanoma. | completed | Phase 2 | 28 | PfizerINDUSTRY | 3 | Oct 27, 2008 | clinicaltrials |
| NCT00099970 | Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy | completed | Phase 2 | 40 | PDL BioPharma, Inc.INDUSTRY | 1 | Aug 5, 2008 | clinicaltrials |
| NCT00656227 | A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision | unknown | Phase 2 | 239 | RenovoINDUSTRY | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00116363 | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma | unknown | Phase 2 | 25 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00001685 | Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase | completed | Phase 2 | 114 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001705 | Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence | completed | Phase 2 | 141 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00066196 | Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma | completed | Phase 2 | 110 | MedImmune LLCINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00383851 | Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma | unknown | Phase 2 | 60 | AttenuonINDUSTRY | 1 | Dec 6, 2007 | clinicaltrials |
| NCT00306514 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 1 / Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 20, 2007 | clinicaltrials |
| NCT00306566 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients | completed | Phase 1 / Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 20, 2007 | clinicaltrials |
| NCT00168870 | Study of Metastatic Ocular Melanoma | unknown | Phase 2 | 48 | Charite University, Berlin, GermanyOTHER | 1 | Aug 31, 2007 | clinicaltrials |
| NCT00232726 | Clinical Study of Previously Untreated Patients With Malignant Melanoma | completed | Phase 2 | 42 | Clavis PharmaINDUSTRY | 3 | Jul 10, 2007 | clinicaltrials |
| NCT00083239 | Study of Talabostat in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00083252 | Study of Talabostat and Cisplatin in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00204607 | Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients | completed | Phase 1 / Phase 2 | 20 | University Hospital TuebingenOTHER | 1 | Apr 19, 2007 | clinicaltrials |
| NCT00294476 | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma | unknown | Phase 2 | 30 | GammaCanINDUSTRY | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00306553 | Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients | completed | Phase 2 | — | Cytos Biotechnology AGINDUSTRY | 1 | Sep 19, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00350597 | GM-CSF as Adjuvant Therapy of Melanoma | completed | Phase 2 | 50 | Northern California Melanoma CenterOTHER | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00111046 | Pain Relief - Tramadol Versus Ibuprofen | unknown | Phase 1 / Phase 2 | 40 | Royal Liverpool University HospitalOTHER_GOV | 1 | Nov 10, 2005 | clinicaltrials |
| NCT00188370 | Ultrasound Biomicroscopy - Apoptosis | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00087477 | A Pilot Study of Pivanex in Patients With Malignant Melanoma | terminated | Phase 1 / Phase 2 | 14 | Titan PharmaceuticalsINDUSTRY | 1 | Aug 30, 2005 | clinicaltrials |
| NCT00006200 | Thalidomide and Dacarbazine for Metastatic Melanoma | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00042497 | Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma | suspended | Phase 2 | 60 | AnosysINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | completed | Phase 2 / Phase 3 | 274 | Celgene CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 2, 2009source: clinicaltrials